This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Teva Pharmaceutical Industries Ltd (TEVA)

NYSE: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 2.23B 1.04B 2.88B 1.10B
Receivables 5.41B 5.34B 5.57B 6.21B
Inventories 4.37B 5.05B 5.50B 5.01B
Other Current Assets 1.40B 1.21B 1.26B 0.00
Total Current Assets 14.40B 13.72B 16.36B 14.45B
Property, Plant & Equipment, Gross 9.88B 9.74B 9.14B 8.38B
Accumulated Depreciation & Depletion 3.34B 3.10B 2.82B 2.43B
Property, Plant & Equipment, Net 6.54B 6.64B 6.32B 5.95B
Intangibles 5.51B 6.48B 7.74B 10.32B
Other Non-Current Assets 1.57B 1.70B 1.34B 991.00M
Total Non-Current Assets 32.02B 33.79B 34.25B 35.69B
Liabilities & Shareholder Equity
Total Assets 46.42B 47.51B 50.61B 50.14B
Accounts Payable 3.17B 3.32B 3.38B 3.74B
Short Term Debt 1.76B 1.80B 3.01B 3.75B
Other Current Liabilities 7.36B 6.84B 6.51B 5.82B
Total Current Liabilities 12.29B 11.96B 12.89B 13.85B
Long Term Debt 8.57B 10.39B 11.71B 10.24B
Deferred Income Taxes 1.10B 1.25B 1.85B 2.61B
Other Non-Current Liabilities 1.11B 1.27B 1.29B 1.11B
Minority Interest -13.00M -16.00M -53.00M 9.00M
Total Non-Current Liabilities 10.82B 12.98B 14.95B 14.10B
Total Liabilities 23.11B 24.94B 27.84B 27.95B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 23.31B 22.56B 22.77B 22.20B
Common Par 50.00M 50.00M 50.00M 50.00M
Additional Paid In Capital 14.12B 13.63B 13.47B 13.37B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 14.44B 12.54B 12.35B 11.28B
Treasury Stock -3.95B -3.56B -3.08B -1.92B
Other Equity Adjustments -1.34B -91.00M -17.00M -589.00M
Total Capitalization 31.88B 32.95B 34.48B 32.43B
Total Equity 23.31B 22.56B 22.77B 22.20B
Total Liabilities & Stock Equity 46.42B 47.51B 50.61B 50.14B
Total Common Shares Outstanding 851.87M 946.87M 856.62M 882.99M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 105.00M 99.00M 87.00M 59.00M
Basic Weighted Shares Outstanding 853.00M 849.00M 872.00M 890.00M
Diluted Weighted Shares Outstanding 858.00M 850.00M 873.00M 893.00M
Number of Employees 43009 45000 45948 45754
Number of Part-Time Employees 0 0 0 0
TEVA News

TEVA Teva Pharmaceutical Industries Ltd

Chart of TEVA

Analysts Ratings for TEVA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 10 9 10 10
Moderate Buy 2 0 0 0
Hold 5 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 0
GET TEVA ANALYST REPORT

Brokerage Partners

TEVA Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs